Hepatitis D virus infection among HIV-HBV co-infected patients in Kermanshah, West of Iran

Hepatitis Monthly

Volumn 8, Issue 4, 2008, Pages 252-257

  Vaziri, Siavash ^a   Mansouri, Feizollah ^a   Sayad, Babak ^a   Afsharian, Mandana ^a   Janbakhsh, Alireza ^a   Karami, Manoochehr ^a  

^a Kermanshah Liver Diseases and Hepatitis Research Center   (Iran)

Author keywords

Co infection; HBV; HDV; HIV; Viral hepatitis

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DELTA AGENT HEPATITIS; DRUG ABUSE; ENDEMIC DISEASE; FEMALE; GENDER; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; INFECTION RISK; IRAN; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PREVALENCE; RISK FACTOR;

EID: 67649228589     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Taylor J. Hepatitis delta virus. [cited 2005 June 10]; Available from: www.fccc.edu/docs/research/hdv.html.
2. Rizzetto M, Verme G. Delta hepatitis - present status. J Hepatol. 1985;1(2):187-93.
3. Gonzalez SA, Talal AH. Hepatitis C virus in human immunodeficiency virus-infected individuals: an emerging comorbidity with significant implications. Semin Liver Dis. 2003;23(2):149-66.
4. González-García J, Guerra L, Amela C, et al. Coinfection by HIV and hepatitis A, B and C virus in adult patients: Practice guidelines for management of HIV infection. Review and GESIDA/ PNS recommendations (2000-2002). 2003.
5. Nelson MR, Matthews G, Brook MG, Main J. BHIVA guidelines: coinfection with HIV and chronic hepatitis C virus. HIV Med. 2003;4 Suppl 1:52-62.
6. Ockenga J, Tillmann HL, Trautwein C, Stoll M, Manns MP, Schmidt RE. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. J Hepatol. 1997;27(1):18-24.
7. Bonacini M. Management issues in patients coinfected with hepatitis C virus and HIV. AIDS Read. 2002;12(1):19-21,4-6.
8. Cribier B, Rey D, Schmitt C, Lang JM, Kirn A, Stoll-Keller F. High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV. AIDS. 1995;9(10):1131-6.
9. Sulkowski MS, Mast EE, Seeff LB, Thomas DL. Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin Infect Dis. 2000;30 Suppl 1:S77-84.
10. Chin J, editor. Control of communicable diseases manual. 17th ed. Washington, DC: American Public Health Association; 2000.
11. Gonzalez-Garcia JJ, Mahillo B, Hernandez S, et al. [Prevalences of hepatitis virus coinfection and indications for chronic hepatitis C virus treatment and liver transplantation in Spanish HIV-infected patients. The GESIDA 29/02 and FIPSE 12185/01 Multicenter Study.]. Enferm Infecc Microbiol Clin. 2005;23(6):340-8.
12. Gaeta GB, Stroffolini T, Chiaramonte M, et al. Chronic hepatitis D: a vanishing Disease? An Italian multicenter study. Hepatology. 2000;32(4 Pt 1):824-7.
13. Buti M, Esteban R, Jardi R, Allende H, Baselga JM, Guardia J. Epidemiology of delta infection in Spain. J Med Virol. 1988; 26(3):327-32.
14. Navascues CA, Rodriguez M, Sotorrio NG, et al. Epidemiology of hepatitis D virus infection: changes in the last 14 years. Am J Gastroenterol. 1995;90(11):1981-4.